weightlossprotips

Condition guide · Clinician-reviewed

GLP-1s for Obstructive Sleep Apnea

In December 2024 the FDA approved Zepbound (tirzepatide) for moderate-to-severe obstructive sleep apnea in adults with obesity — the first medication ever approved for OSA. This expanded insurance coverage for many patients who previously couldn't access weight-loss GLP-1s.

Clinical evidence

  • SURMOUNT-OSA (2024): Zepbound reduced apnea-hypopnea index (AHI) by 25–29 events/hour vs placebo, a ~63% reduction at 52 weeks.
  • Patients without CPAP at baseline saw AHI normalize (< 5 events/hour) in 43% of cases on the highest dose.
  • Weight loss averaged 18–20% — comparable to SURMOUNT-1 weight-loss trial results.
  • First-ever pharmacologic OSA indication — FDA approval December 2024.

Preferred medications

Zepbound

Dual GIP/GLP-1 receptor agonist · 2.5 mg → 15 mg weekly

Zepbound is Eli Lilly's tirzepatide-based weight-loss injection. See average pricing, dosing, and which telehealth brands can prescribe it through insurance.

Read full guide

Programs we recommend

  1. #1 Editor's pick

    Ro (Body)

    Brand-name Wegovy & Zepbound through insurance

    4.4
    $145/mo starting
    • Helps navigate insurance for brand-name GLP-1s
    • Polished mobile app and tracking
    • Access to compounded alternatives if insurance denies
    • Medication cost is separate when using insurance
    🎁 Current offer

    $99 first month

    Category:Telehealth GLP-1Coverage:All 50 statesInsurance:Accepted
    Read full reviewVisit ↗
  2. #2 Top rated

    Mochi Health

    Obesity-medicine specialists with insurance navigation

    4.7
    $79/mo starting
    • Membership-only model is the cheapest entry point
    • Board-certified obesity medicine physicians
    • Will prescribe non-GLP-1 alternatives when appropriate
    • Medication paid separately
    🎁 Current offer

    $0 first visit

    Category:Prescription ProgramCoverage:All 50 statesInsurance:Accepted
    Read full reviewVisit ↗
  3. #3 Top rated

    Found

    Behavior-change first, medication when appropriate

    4.2
    $99/mo starting
    • Strong coaching curriculum
    • Personalized medication selection
    • Transparent about non-medication paths
    • Less GLP-1-centric than competitors
    🎁 Current offer

    First month $99

    Category:Prescription ProgramCoverage:All 50 statesInsurance:Accepted
    Read full reviewVisit ↗

Clinical considerations

An OSA diagnosis (typically AHI ≥ 15) plus obesity (BMI ≥ 30) is required for the on-label indication. A sleep study is needed for diagnosis if you don't already have one. Zepbound for OSA is NOT a CPAP replacement for severe cases — it should be considered alongside or as a step-down from CPAP under clinician supervision.

FAQ

GLP-1s for Obstructive Sleep Apnea FAQs

Yes. The FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity in December 2024 — the first prescription medication ever indicated for OSA.

Other condition guides

GLP-1s for Type 2 Diabetes & Prediabetes

Read guide

Related cost, coverage & program reviews

Cost

GLP-1 pricing breakdown

What you'll pay with and without insurance in 2026.

Open

Insurance

Coverage by insurer

BCBS, UHC, Aetna, Cigna, Kaiser & Medicare matrix.

Open

Head-to-head

Ro vs Mochi Health

Both prescribe brand-name Wegovy and Zepbound.

Open

Head-to-head

Hims vs Medvi

Cheapest compounded semaglutide programs compared.

Open

By state

GLP-1 in California

Local prescribing rules and licensed programs.

Open

By state

GLP-1 in Florida

Florida prescribing landscape and top brands.

Open